PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Nov-2023 KalVista Pharmaceuticals to Present at Upcoming Investor Conferences Businesswire
07-Nov-2023 InfuSystem Reports Third Quarter 2023 Financial Results Businesswire
07-Nov-2023 Amneal Reports Third Quarter 2023 Financial Results Businesswire
07-Nov-2023 Beckman Coulter Life Sciences and Pillar Biosciences Announce NGS Application Development Pipeline for the Biomek NGeniuS System  Beckman Coulter Life Sciences
07-Nov-2023 AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity Newswire
07-Nov-2023 BioMed X Launches a New Call for Application in Autoimmune Disease Research Newswire
07-Nov-2023 Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update Businesswire
07-Nov-2023 L&T Technology Services to partner with Google Cloud to develop state-of-the-art DevX platform Businesswire
07-Nov-2023 Aura Biosciences Announces Pricing of Public Offering of Common Stock Businesswire
07-Nov-2023 Il Comitato per il ripristino del valore per gli azionisti Nymox offre agli azionisti Nymox un aggiornamento fattuale sulla Riunione speciale Businesswire
07-Nov-2023 Het Committee to Restore Nymox Shareholder Value biedt inhoudelijke update aan de Nymox-aandeelhouders met betrekking tot de Speciale Vergadering Businesswire
07-Nov-2023 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
07-Nov-2023 Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-Line Treatment for Upper GI Cancers Businesswire
07-Nov-2023 Redwire Corporation Reports Third Quarter 2023 Financial Results Businesswire
07-Nov-2023 Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-line Treatment for Upper GI Cancers Businesswire
07-Nov-2023 MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock Businesswire
07-Nov-2023 El Committee to Restore Nymox Shareholder Value proporciona información actualizada a los accionistas de Nymox sobre la Asamblea Especial Businesswire
07-Nov-2023 Das Committee to Restore Nymox Shareholder Value informiert die Nymox-Aktionäre über die außerordentlichen Versammlung Businesswire
07-Nov-2023 Fabrinet Announces First Quarter Fiscal Year 2024 Financial Results Businesswire
07-Nov-2023 Aura Biosciences Announces Proposed Public Offering of Common Stock Businesswire